Want to see JP:7079 full AI Analyst Report?
WDB coco Co., Ltd. (7079) AI Stock Analysis
WDB coco Co., Ltd.
(TSE/TYO:7079)
The stock scores a 77, driven primarily by exceptional balance sheet strength and a highly attractive valuation, though offset by recent top-line contraction and neutral technical momentum. The company provides strong downside protection with virtually no debt and offers a solid 3.65% dividend yield at a significant discount. However, the lack of current technical catalysts and a recent 9.2% decline in revenue signal that stabilization in top-line growth is necessary to ignite further upward price movement.
WDB coco Co., Ltd. (7079) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 6.17B
- Dividend Yield
- 3.70%
- Average Volume (3M)
- 1,669
- Price to Earnings (P/E)
- 0.9
- Beta (1Y)
- 0.24
- Revenue Growth
- -11.16%
- EPS Growth
- -21.80%
- Country
- Japan
- Employees
- 516
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Specialty Business Services
WDB coco Co., Ltd. Business Overview & Revenue Model
Company Description
WDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support...
How the Company Makes Money
null
WDB coco Co., Ltd. Financial Statement Overview
Summary
Solid overall financial health anchored by a pristine, virtually debt-free balance sheet (D/E of 0.01x) and strong free cash flow conversion. This robust foundation helps buffer against recent operational headwinds, including a 9.2% revenue decline and margin compression in fiscal 2026.
Income Statement
65PositiveBalance Sheet
92Very PositiveCash Flow
72Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.02B | 4.82B | 5.33B | 4.60B | 4.07B | 3.62B |
| Gross Profit | 18.29B | 1.71B | 2.07B | 1.93B | 1.58B | 1.44B |
| EBITDA | 9.54B | 1.01B | 1.36B | 1.31B | 1.12B | 981.71M |
| Net Income | 6.54B | 679.31M | 912.90M | 857.83M | 743.63M | 647.70M |
Balance Sheet | ||||||
| Total Assets | 261.84B | 5.70B | 5.60B | 4.67B | 3.67B | 3.14B |
| Cash, Cash Equivalents and Short-Term Investments | 176.04B | 3.76B | 3.48B | 2.66B | 2.00B | 1.89B |
| Total Debt | 2.20B | 80.41M | 29.81M | 27.12M | 24.32M | 33.52M |
| Total Liabilities | 52.39B | 921.26M | 1.30B | 1.10B | 866.02M | 994.57M |
| Stockholders Equity | 209.45B | 4.78B | 4.30B | 3.56B | 2.80B | 2.15B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 521.82M | 1.10B | 753.84M | 469.46M | 719.72M |
| Operating Cash Flow | 0 | 570.54M | 1.10B | 772.20M | 517.49M | 747.90M |
| Investing Cash Flow | 0 | -80.53M | -88.33M | -91.82M | -302.97M | -60.48M |
| Financing Cash Flow | 0 | -207.03M | -195.83M | -110.94M | -101.21M | -79.11M |
WDB coco Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7079, the sentiment is Negative. The current price of 2565.00 is below the 20-day moving average (MA) of 2569.55, below the 50-day MA of 2573.48, and below the 200-day MA of 2596.53, indicating a bearish trend. The MACD of -7.47 indicates Positive momentum. The RSI at 48.55 is Neutral, neither overbought nor oversold. The STOCH value of 56.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7079.
WDB coco Co., Ltd. Peers Comparison
Overall Rating
- JP:707977Outperform
JP:489250Neutral
JP:453946.5Neutral
JP:488342Neutral
JP:458237Underperform
JP:458637Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7079 | 77Outperform | JPY 6.13B | 0.94 | ― | 3.70% | -11.16% | -21.80% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4892 | 50Neutral | JPY 5.64B | -6.65 | ― | ― | 364.72% | 18.43% |
| JP:4539 | 47Neutral | JPY 5.47B | -11.34 | ― | 3.35% | 0.31% | -194.72% |
| JP:4883 | 42Neutral | JPY 3.18B | -1.12 | ― | ― | ― | -5.66% |
| JP:4582 | 37Underperform | JPY 3.72B | -0.47 | ― | ― | -30.58% | 6.93% |
| JP:4586 | 37Underperform | JPY 3.29B | -2.95 | ― | ― | 167.44% | 49.38% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7079 | WDB coco Co., Ltd. | 2565.00 | -8.81 | -0.34% | |
| JP:4539 | Nippon Chemiphar Co., Ltd. | 1494.00 | 9.29 | 0.63% | |
| JP:4582 | Symbio Pharmaceuticals Limited | 43.00 | -72.00 | -62.61% | |
| JP:4586 | Medrx Co., Ltd. | 42.00 | -87.00 | -67.44% | |
| JP:4883 | Modalis Therapeutics Corporation | 27.00 | -48.00 | -64.00% | |
| JP:4892 | Cyfuse Biomedical K.K. | 541.00 | -44.00 | -7.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026